Position in ACLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$27,354,142
New position
Shares Held
238,235
first reported quarter
Ownership
0.407%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026First Trust Capital Management L.P. holds $141,440,897 across 5 Biotechnology names. ACLX ranks #3 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
904,161 | $47,667,367 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
1,496,007 | $32,074,389 | |
| 3 | ACLX |
Arcellx, Inc.
This page
|
238,235 | $27,354,142 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,399,192 | $20,232,315 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
350,800 | $14,112,684 |
All Filings in ACLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,354,142 | 238,235 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||